HMGB1 and Parkinson disease: Release of proinflammatory cytokines (AD, PD, ALS, stroke); blocks anti-inflammatory action of microglial TREM2 (AD); production of NLRP3 inflammasome (PD); HMGB1-induced activation in stroke; modulation of allodynia (AD)